Dysregulated m6A Modification Promotes Lipogenesis and Development of Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Scientists developed a new non-alcoholic fatty liver disease model oriented from a type 2 diabetes mellitus mouse, which spontaneously progressed to histological features of non-alcoholic steatohepatitis, fibrosis and HCC with high incidence.